메뉴 건너뛰기




Volumn 34, Issue 10, 2016, Pages 1057-1064

Role of adjuvant therapy in a population-based cohort of patients with early-stage small-cell lung cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 84963576808     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.8171     Document Type: Article
Times cited : (162)

References (24)
  • 1
    • 0033762003 scopus 로고    scopus 로고
    • Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan
    • Inoue M, Miyoshi S, Yasumitsu T, et al: Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. Ann Thorac Surg 70:1615-1619, 2000
    • (2000) Ann Thorac Surg , vol.70 , pp. 1615-1619
    • Inoue, M.1    Miyoshi, S.2    Yasumitsu, T.3
  • 2
    • 4644281263 scopus 로고    scopus 로고
    • Small cell lung cancer in Norway: Should more patients have been offered surgical therapy?
    • Rostad H, Naalsund A, Jacobsen R, et al: Small cell lung cancer in Norway: Should more patients have been offered surgical therapy? Eur J Cardiothorac Surg 26:782-786, 2004
    • (2004) Eur J Cardiothorac Surg , vol.26 , pp. 782-786
    • Rostad, H.1    Naalsund, A.2    Jacobsen, R.3
  • 3
    • 19944416865 scopus 로고    scopus 로고
    • Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come
    • Brock MV, Hooker CM, Syphard JE, et al: Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. J Thorac Cardiovasc Surg 129:64-72, 2005
    • (2005) J Thorac Cardiovasc Surg , vol.129 , pp. 64-72
    • Brock, M.V.1    Hooker, C.M.2    Syphard, J.E.3
  • 4
    • 58949089257 scopus 로고    scopus 로고
    • The role of surgery in the treatment of limited disease small cell lung cancer: Time to reevaluate
    • Lim E, Belcher E, Yap YK, et al: The role of surgery in the treatment of limited disease small cell lung cancer: Time to reevaluate. J Thorac Oncol 3:1267-1271, 2008
    • (2008) J Thorac Oncol , vol.3 , pp. 1267-1271
    • Lim, E.1    Belcher, E.2    Yap, Y.K.3
  • 7
    • 0025741590 scopus 로고
    • Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer: Rationale for current approach
    • Macchiarini P, Hardin M, Basolo F, et al: Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer: Rationale for current approach. Am J Clin Oncol 14:218-224, 1991
    • (1991) Am J Clin Oncol , vol.14 , pp. 218-224
    • Macchiarini, P.1    Hardin, M.2    Basolo, F.3
  • 8
    • 0028835205 scopus 로고
    • Surgery for cure followed by chemotherapy in small cell carcinoma of the lung
    • Karrer K, Ulsperger E; for the ISC-Lung Cancer Study Group: Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. Acta Oncol 34:899-906, 1995
    • (1995) Acta Oncol , vol.34 , pp. 899-906
    • Karrer, K.1    Ulsperger, E.2
  • 9
    • 0032192544 scopus 로고    scopus 로고
    • Long-term results of surgery and chemotherapy in small cell lung cancer
    • Rea F, Callegaro D, Favaretto A, et al: Long-term results of surgery and chemotherapy in small cell lung cancer. Eur J Cardiothorac Surg 14:398-402, 1998
    • (1998) Eur J Cardiothorac Surg , vol.14 , pp. 398-402
    • Rea, F.1    Callegaro, D.2    Favaretto, A.3
  • 10
    • 18244364827 scopus 로고    scopus 로고
    • Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)
    • Tsuchiya R, Suzuki K, Ichinose Y, et al: Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 129:977-983, 2005
    • (2005) J Thorac Cardiovasc Surg , vol.129 , pp. 977-983
    • Tsuchiya, R.1    Suzuki, K.2    Ichinose, Y.3
  • 11
    • 0345062339 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
    • Aupérin A, Arriagada R, Pignon JP, et al; Prophylactic Cranial Irradiation Overview Collaborative Group: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341:476-484, 1999
    • (1999) N Engl J Med , vol.341 , pp. 476-484
    • Aupérin, A.1    Arriagada, R.2    Pignon, J.P.3
  • 12
    • 84899988436 scopus 로고    scopus 로고
    • Prevalence and predictors of neoadjuvant therapy for stage IIIA nonsmall cell lung cancer in the National Cancer Database: Importance of socioeconomic status and treating institution
    • Sher DJ, Liptay MJ, Fidler MJ: Prevalence and predictors of neoadjuvant therapy for stage IIIA nonsmall cell lung cancer in the National Cancer Database: Importance of socioeconomic status and treating institution. Int J Radiat Oncol Biol Phys 89:303-312, 2014
    • (2014) Int J Radiat Oncol Biol Phys , vol.89 , pp. 303-312
    • Sher, D.J.1    Liptay, M.J.2    Fidler, M.J.3
  • 14
    • 62449138275 scopus 로고    scopus 로고
    • Combined small cell lung carcinomas: Genotypic and immunophenotypic analysis of the separate morphologic components
    • Wagner PL, Kitabayashi N, Chen YT, et al: Combined small cell lung carcinomas: Genotypic and immunophenotypic analysis of the separate morphologic components. AmJ Clin Pathol 131:376-382, 2009
    • (2009) AmJ Clin Pathol , vol.131 , pp. 376-382
    • Wagner, P.L.1    Kitabayashi, N.2    Chen, Y.T.3
  • 16
    • 84948384227 scopus 로고    scopus 로고
    • Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non-small-cell lung cancer (RADIANT): A randomized, double-blind, phase III trial
    • Kelly K, Altorki NK, Eberhardt WE, et al: Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non-small-cell lung cancer (RADIANT): A randomized, double-blind, phase III trial. J Clin Oncol 33:4007-4014, 2015
    • (2015) J Clin Oncol , vol.33 , pp. 4007-4014
    • Kelly, K.1    Altorki, N.K.2    Eberhardt, W.E.3
  • 17
    • 84874738674 scopus 로고    scopus 로고
    • Time to adjuvant chemotherapy and survival in non-small cell lung cancer: A population-based study
    • Booth CM, Shepherd FA, Peng Y, et al: Time to adjuvant chemotherapy and survival in non-small cell lung cancer: A population-based study. Cancer 119:1243-1250, 2013
    • (2013) Cancer , vol.119 , pp. 1243-1250
    • Booth, C.M.1    Shepherd, F.A.2    Peng, Y.3
  • 19
    • 84877651488 scopus 로고    scopus 로고
    • Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed-American College of Chest Physicians evidence-based clinical practice guidelines
    • Jett JR, Schild SE, Kesler KA, et al: Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed-American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e400Se419S, 2013
    • (2013) Chest , vol.143 , pp. e400Se419S
    • Jett, J.R.1    Schild, S.E.2    Kesler, K.A.3
  • 20
    • 65449145578 scopus 로고    scopus 로고
    • Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): A randomised clinical trial
    • Le Péchoux C, Dunant A, Senan S, et al; Prophylactic Cranial Irradiation (PCI) Collaborative Group: Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): A randomised clinical trial. Lancet Oncol 10:467-474, 2009
    • (2009) Lancet Oncol , vol.10 , pp. 467-474
    • Le Péchoux, C.1    Dunant, A.2    Senan, S.3
  • 21
    • 33947304369 scopus 로고    scopus 로고
    • Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer
    • Petersen RP, Pham D, Burfeind WR, et al: Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 83:1245-1250, 2007
    • (2007) Ann Thorac Surg , vol.83 , pp. 1245-1250
    • Petersen, R.P.1    Pham, D.2    Burfeind, W.R.3
  • 22
    • 77649142718 scopus 로고    scopus 로고
    • Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer
    • Yu JB, Decker RH, Detterbeck FC, et al: Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 5:215-219, 2010
    • (2010) J Thorac Oncol , vol.5 , pp. 215-219
    • Yu, J.B.1    Decker, R.H.2    Detterbeck, F.C.3
  • 23
    • 80051784354 scopus 로고    scopus 로고
    • Lobectomy leads to optimal survival in early-stage small cell lung cancer: A retrospective analysis
    • Varlotto JM, Recht A, Flickinger JC, et al: Lobectomy leads to optimal survival in early-stage small cell lung cancer: A retrospective analysis. J Thorac Cardiovasc Surg 142:538-546, 2011
    • (2011) J Thorac Cardiovasc Surg , vol.142 , pp. 538-546
    • Varlotto, J.M.1    Recht, A.2    Flickinger, J.C.3
  • 24
    • 84864872321 scopus 로고    scopus 로고
    • Surgical resection should be considered for stage I and II small cell carcinoma of the lung
    • Weksler B, Nason KS, Shende M, et al: Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg 94:889-893, 2012
    • (2012) Ann Thorac Surg , vol.94 , pp. 889-893
    • Weksler, B.1    Nason, K.S.2    Shende, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.